openPR Logo
Press release

Bispecific Antibodies Market Opportunity Analysis, 2018-2026

08-17-2018 03:56 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Bispecific Antibodies Market Opportunity Analysis, 2018-2026

Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a technologically advanced solution for dual targeting strategies within same molecule.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/19

Due to its dual specificity, bispecific antibody can aid in redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. Catumaxomab and blinatumomab are the two U.S. FDA approved bispecific antibody products, which would fuel growth of the bispecific antibodies market. Bispecific antibodies can be divided into three main classes namely, fragment, symmetric, and asymmetric antibodies. Fragment bispecific antibodies such as a nanobody DART and BiTE are currently undergoing clinical trials. Likewise, tetravalent BsAb - DVD and DAF symmetric antibodies are under research. Companies such as Sanofi S.A., Merck & Co., Inc. and Genentech, Inc. are conducting research on symmetric bispecific antibodies. BEAT, duobody, and crossmab are examples of asymmetric bispecific antibodies, which are currently being researched by Glenmark Pharmaceuticals, Eli Lilly and Company, and Genmab A/S.

Catumaxomab – the first Bispecific antibody boost growth of the bispecific antibodies market

As of 2015, over 60 different BsAb formats have been developed, with some making their way into the clinical trials. Bispecific antibodies market growth is increasing due to the limitation of monoclonal antibodies in drug resistance and failure to respond in treatment. Hence, the bispecific antibodies market is projected to gain significant growth traction in the near future.

Catumaxomab is a rat – mouse hybrid monoclonal bispecific trifunctional antibody used to treat malignant ascites. It was developed by Fresenius Biotech and Trion Pharma. Catumaxomab was approved in Europe in 2009 and is undergoing clinical trials in the U.S. Sold under the brand name Removab, Catumaxomab is administered to patients with EpCAM-poisitve carcinoma.

North America and Europe are major regions for Bispecific antibodies market

In Europe and North America, incidence of diseases such as lung cancer, cervical cancer, breast cancer, and prostate cancer is increasing, with the regions accounting for the highest incidence rate for these diseases worldwide. Moreover, with these regions being home to major players, these are the largest bispecific antibodies market. Supportive government initiatives are further fueling growth of bispecific antibody treatment markets in North America and Europe. Increasing healthcare access and awareness in developing regions such as Asia Pacific, Latin America, and Middle East are projected to propel demand for BsAb owing to fuel growth of the bispecific antibodies market in the near future.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/19

Increasing investments to harness the potential of highly effective BsAb Drug Therapy

Various pharmaceutical companies are actively involved in development and manufacture of bispecific antibodies. MedImmune, LLC and Abpro, collaborated in December 2016 to develop novel bispecific antibody, Ang2-VEGF, which targets angiopoietin-2 and vascular endothelial growth factor. Government funding is projected to further encourage research and development in this field.

Key players involved in the Bispecific antibodies market include

Some of the key players in Bispecific antibodies market are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and F. Hoffmann-La Roche AG.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bispecific Antibodies Market Opportunity Analysis, 2018-2026 here

News-ID: 1186157 • Views: 177

More Releases from Coherent Market Insights

Bioacoustics Sensing Market | Opportunities, Applications, Drivers And Limitatio …
Bioacoustics is branch of science that combines biology and acoustics. It is associated with the production, control, transmission, reception, and effects of sound on animals as well as humans. It is used to understand the relationship between features of sounds animals produce, the nature of the environment in which they are used, and the functions they are designed to serve. The technology records and analyzes ultrasound and vibration by using
Sensor Market : Research Observes Strong CAGR Development
Sensor is a device that detects different types of physical input such as light, heat, motion, moisture, and pressure, among others. This data transmits to an electronic device for further processing. Sensors find applications in various industries such as electronics, IT & telecommunication, automotive, and healthcare. Increasing utilization of internet of things (IoT) is a major factor expected to boost growth of the global sensors market. Major benefits associated with
What are the Light Sensors Market Trends? Scope Along With Top Key Players Avago …
The light sensor converts light input into corresponding electrical output. It is used in the automatic street light systems, automatic brightness control in mobile, and security devices in home and offices, which helps in minimizing the power consumption of the devices. Most commonly used light sensors are based on photoresistors, which control the flow of current using sensed light energy. These are known as Light Dependent Resistors (LDRs). Get Sample
What Challenges Global MOSFET and IGBT Gate Drivers Market May See In Upcoming Y …
MOSFET and IGBT are two switch mode power supply transistors. A Metal-Oxide-Semiconductor Field Effect Transistor (MOSFET) is a field Effect Transistor that is typically formed by controlled oxidation of silicon. It uses insulated gates, which enabled changing conductivity with the variation of applied voltage as per application requirement. This property is used in amplifying or switching electric signals. An Insulated-gate Bipolar Transistor (IGBT) is a three terminal power semiconductor device,

All 5 Releases


More Releases for Bispecific

Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 20 …
Engineered Bispecific Antibodies (BsAb) Wiseguyreports.Com Adds “Engineered Bispecific Antibodies (BsAb) Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Get Sample Report @ https://www.wiseguyreports.com/sample-request/476535-engineered-bispecific-antibodies-bsab-novel-approaches-pipeline-insights-2016 Covered In This Report: Summary DelveInsight Report, “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication
Bispecific Antibodies Market, Company Analysis and Forecast to 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market to Grow Globally
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market with business strategies and analysis to 2021
Bispecific antibodies are one of the fastest developing markets in the field of immune response therapeutics, medications and biologics.. Bispecific antibodies are combination of two antibodies which address distinctive antigens. Bispecific antibodies can recognize a single antigen target also they can identify two different targets at the same time. In recent years, antibody therapy has become a new treatment for various diseases. A bispecific antibody is an upgraded side of